AAAAAA
Results:
1-9
|
Results: 9
Authors:
Sorbera, LA
Revel, L
Castaner, J
Citation: La. Sorbera et al., P32/98. Antidiabetic, dipeptidyl-peptidase IV inhibitor., DRUG FUTURE, 26(9), 2001, pp. 859-864
Authors:
Sorbera, LA
Castaner, RM
Revel, L
Citation: La. Sorbera et al., Abetimus sodium - Treatment of systemic lupus etythematosus, DRUG FUTURE, 26(7), 2001, pp. 633-638
Authors:
Sorbera, LA
Revel, L
Fernandez, R
Citation: La. Sorbera et al., Alefacept. Antipsoriatic, DRUG FUTURE, 26(6), 2001, pp. 527-532
Authors:
Sorbera, LA
Leeson, PA
Graul, A
Revel, L
Citation: La. Sorbera et al., hu1124 - Antipsoriatic - Treatment of transplant rejection, DRUG FUTURE, 26(3), 2001, pp. 232-238
Authors:
Sorbera, LA
Revel, L
Martin, L
Castaner, J
Citation: La. Sorbera et al., Escitalopram oxalate - Antidepressant - 5-HT reuptake inhibitor, DRUG FUTURE, 26(2), 2001, pp. 115-120
Authors:
Sorbera, LA
Revel, L
Rabasseda, X
Castaner, J
Citation: La. Sorbera et al., TMX-67 - Treatment of gout and hyperuricemia - Xanthine oxidase inhibitor, DRUG FUTURE, 26(1), 2001, pp. 32-38
Authors:
Revel, L
Sorbera, LA
Martin, L
Citation: L. Revel et al., Teriparatide. Treatment of osteoporosis, parathyroid hormone analog., DRUG FUTURE, 25(8), 2000, pp. 803-808
Authors:
Revel, L
Makovec, F
Citation: L. Revel et F. Makovec, Discovery of new CCK2 receptor antagonists. A review of pharmacological studies. Part I: Development of potential therapeutic tools for gastrin-related gastrointestinal diseases, METH FIND E, 21(5), 1999, pp. 375-383
Authors:
Makovec, F
Revel, L
Letari, O
Mennuni, L
Impicciatore, M
Citation: F. Makovec et al., Characterization of antisecretory and antiulcer activity of CR 2945, a newpotent and selective gastrin/CCKB receptor antagonist, EUR J PHARM, 369(1), 1999, pp. 81-90
Risultati:
1-9
|